Hong Kong Intellectual Property Royalties for US Persons: Ordinary Income vs Capital Gain Treatment

The US tax treatment of intellectual property (IP) royalties derived from Hong Kong has become a critical planning point for US persons residing in the territory, particularly as the IRS sharpens its focus on cross-border intangible property transactions. A 2024 IRS Large Business & International (LB&I) campaign specifically targets the “Transfer Pricing for High-Risk Cross-Border Transactions,” with IP royalty streams a primary area of scrutiny. For a US citizen or Green Card holder living in Hong Kong, the question of whether royalty income from a Hong Kong source is classified as ordinary income or capital gain is not a matter of elective character; it is a statutory determination under the Internal Revenue Code (IRC) that carries significant rate differentials. Ordinary income from royalties is taxed at graduated rates up to 37%, while long-term capital gains on the sale of a qualifying IP asset face a top rate of 20% (plus the 3.8% Net Investment Income Tax, or NIIT). The distinction hinges on whether the US person is receiving periodic payments for the use of IP (ordinary income) or realizing a gain from the disposition of a capital asset (capital gain). This article examines the statutory framework under IRC § 1221, the application of the Hong Kong-US Tax Information Exchange Agreement (TIEA) for substance, and the practical pitfalls for Hong Kong-based US persons holding patents, trademarks, or copyrights.

The Statutory Distinction: IRC § 1221 and the Definition of a Capital Asset

The foundational question for US tax purposes is whether the IP held by the US person constitutes a capital asset under IRC § 1221. A capital asset is broadly defined as property held by the taxpayer, with specific exclusions. The most relevant exclusion for IP holders is IRC § 1221(a)(3), which excludes from capital asset treatment a copyright; a literary, musical, or artistic composition; a letter or memorandum; or similar property held by a taxpayer whose personal efforts created such property. This means a US person who personally creates a patent or copyright in Hong Kong will generally not hold that IP as a capital asset. The gain on its sale is treated as ordinary income under IRC § 1221(a)(3)(A). For a US person who purchases or inherits IP, the analysis shifts to whether the asset is held for investment (capital asset) or for use in a trade or business (potentially depreciable property under IRC § 1231, which can produce capital gain on disposition).

The “Held for Sale to Customers” Trap

A further layer of complexity arises under IRC § 1221(a)(1), which excludes from capital asset treatment property held primarily for sale to customers in the ordinary course of the taxpayer’s trade or business. A Hong Kong-based US person who develops IP with the intention of licensing it out as a primary business activity—for example, a software developer who licenses a proprietary algorithm to multiple Hong Kong companies—runs the risk that the IRS will recharacterize the IP as inventory or dealer property. In such a case, even a one-time sale of the entire IP portfolio would yield ordinary income. The US Tax Court in F.S. Services, Inc. v. Commissioner, 1980, held that a taxpayer’s intent at the time of acquisition (or creation) is the controlling factor. For a US person in Hong Kong, contemporaneous documentation of investment intent—such as a written IP holding strategy or a family office investment memorandum—is essential to preserve capital gain treatment.

The Depreciation Recapture Rule: IRC § 1245 and § 1250

If the IP is held for use in a trade or business (e.g., a US person in Hong Kong who licenses a patent to a Hong Kong subsidiary as part of an active business), the IP is likely depreciable property under IRC § 167. The sale of such property is governed by IRC § 1231, which can yield capital gain if the overall gains from § 1231 property exceed losses. However, IRC § 1245 recaptures as ordinary income any depreciation previously claimed on the IP, up to the amount of the gain. For a Hong Kong-based US person who has claimed significant depreciation deductions on a purchased patent (e.g., a 15-year amortization schedule under IRC § 197), the sale of that patent will generate ordinary income to the extent of the cumulative depreciation. The remaining gain, if any, may qualify as capital gain under IRC § 1231.

The Source of Royalty Income: Hong Kong Territoriality vs. US Worldwide Taxation

A US person living in Hong Kong is subject to US federal income tax on their worldwide income, regardless of where the income is sourced. However, the source of the royalty income determines the availability of the Foreign Tax Credit (FTC) under IRC § 901, and whether the income is eligible for the Foreign Earned Income Exclusion (FEIE) under IRC § 911—though royalties are generally not “earned income” for FEIE purposes. Under IRC § 861(a)(4), royalties for the use of intangible property in the United States are sourced to the United States. Conversely, royalties for the use of property outside the United States are sourced to the foreign country. For a Hong Kong-based US person licensing IP to a Hong Kong entity for use solely in Hong Kong, the royalty income is foreign-source income. This allows the taxpayer to claim a FTC against US tax liability, subject to the limitation under IRC § 904.

The Hong Kong Source Rule and the Tax Treaty

Hong Kong, under the Inland Revenue Ordinance (Cap. 112), taxes royalties on a territorial basis. Section 15(1)(a) of the IRO deems royalties paid to a non-resident for the use of intellectual property in Hong Kong as assessable to Hong Kong profits tax. For a US person resident in Hong Kong, the Hong Kong-US TIEA (entered into force in 2014) provides a framework for the exchange of information but does not provide for reduced withholding rates on royalties, as Hong Kong does not have a comprehensive double tax treaty with the United States. This means a US person receiving royalties from a Hong Kong payer faces a 4.95% Hong Kong profits tax on the gross royalty (under the standard corporate rate, as the individual rate for unincorporated businesses is the standard rate of 15%, but the profits tax rate on royalties is generally the standard corporate rate). The US person must report this gross royalty on their US tax return and claim a FTC for the Hong Kong tax paid. The FTC is limited to the US tax attributable to the foreign-source income, calculated on a per-country or overall basis under IRC § 904.

The Substance Over Form Doctrine: The “Economic Substance” Risk

The IRS has increasingly applied the economic substance doctrine under IRC § 7701(o) to IP royalty arrangements. A Hong Kong-based US person who structures a licensing arrangement with a related Hong Kong entity—for example, a US person who owns a patent and licenses it to a Hong Kong company they also control—must ensure the arrangement has economic substance beyond tax avoidance. The IRS will examine whether the royalty rate is arm’s length under IRC § 482 (transfer pricing). The Hong Kong Inland Revenue Department (IRD) also scrutinizes such arrangements under the transfer pricing rules introduced in 2018 (Inland Revenue (Amendment) (No. 6) Ordinance 2018). A mismatch between the US and Hong Kong tax treatment—where the US treats the royalty as ordinary income and Hong Kong treats it as a deductible expense for the payer—can trigger an IRS audit. The 2024 IRS LB&I campaign specifically targets “Base Erosion and Profit Shifting (BEPS) transactions involving intangible property,” with a focus on related-party licensing.

Structuring for Capital Gain: The Sale of IP vs. Licensing

For a US person in Hong Kong seeking capital gain treatment on IP, the optimal path is a sale of the entire IP asset to an unrelated third party, rather than a licensing arrangement. A sale is a disposition of the entire bundle of rights, while a license is a grant of permission to use—the latter always yields ordinary income to the licensor. Under IRC § 1222, the holding period for long-term capital gain treatment is more than one year. A US person who creates IP and holds it for investment for at least one year before selling it to a Hong Kong company (unrelated) may qualify for long-term capital gain treatment, provided the IP is not excluded under IRC § 1221(a)(3) (i.e., the taxpayer did not create it through their personal efforts). For purchased IP, the holding period begins on the date of acquisition.

The “Sale vs. License” Distinction in US Tax Law

The US Tax Court in Pickren v. Commissioner, 1985, articulated a multi-factor test to distinguish a sale from a license. Key factors include: (1) whether the transferor retains any substantial rights in the IP (e.g., the right to terminate the license, the right to sublicense, or the right to improvements); (2) whether the transferee receives all substantial rights; and (3) whether the consideration is contingent on use (royalties) or fixed (lump sum). A lump-sum payment for the transfer of all substantial rights in a patent, with no ongoing royalty stream, is more likely to be treated as a sale. A Hong Kong-based US person who structures a sale to a Hong Kong entity must ensure the purchase price is arm’s length and supported by a valuation report. The IRS may challenge the character of the transaction if the “sale” is followed by the US person continuing to provide services related to the IP, as this suggests the retention of an economic interest.

The Exit Strategy: US Exit Tax and IP Migration

For a US person who is a long-term resident (Green Card holder for 8 of the last 15 years) or a US citizen considering relinquishing their US status, the treatment of IP under IRC § 877A (the exit tax) is a critical consideration. The exit tax treats all property of the covered expatriate as sold for its fair market value on the day before expatriation. IP held by the expatriate—including patents, copyrights, and trademarks—is subject to this deemed sale. The gain is recognized as ordinary income or capital gain based on the same principles outlined above. A Hong Kong-based US person who holds a valuable patent portfolio and considers expatriation must plan for the exit tax liability. The IRS has issued guidance (Notice 2009-85) on the valuation of intangible property for exit tax purposes. Structuring the IP in a foreign trust or corporation before expatriation may trigger additional anti-deferral rules under IRC § 679 (foreign trusts with US beneficiaries) or IRC § 367 (outbound transfers of property).

Practical Considerations for Hong Kong-Based US Persons

The intersection of Hong Kong’s territorial tax system and US worldwide taxation creates specific compliance obligations for US persons receiving IP royalties. The US person must file Form 1040 annually, reporting all royalty income as “Other Income” on Schedule 1 (Line 8z) or, if from a trade or business, on Schedule C. If the royalty income exceeds USD 200,000 (or USD 150,000 for married filing separately), the taxpayer must also file Form 8938 (Statement of Specified Foreign Financial Assets) if the foreign financial assets (including the IP licensing agreement itself, if it is a contract right) exceed the applicable threshold. For a Hong Kong-based US person, the IP licensing agreement with a Hong Kong entity is a specified foreign financial asset if its value exceeds the threshold. The FBAR (FinCEN Form 114) reporting requirement applies if the US person has a financial interest in or signature authority over a foreign financial account, including a Hong Kong bank account holding royalty payments, with an aggregate value exceeding USD 10,000 at any time during the calendar year.

The Statute of Limitations and Examination Risk

The IRS generally has three years from the date of filing to assess additional tax (IRC § 6501). However, if the taxpayer omits gross income exceeding 25% of the gross income stated on the return, the statute of limitations extends to six years. For a US person in Hong Kong who fails to report royalty income or mischaracterizes it as capital gain, the six-year statute applies. The IRS’s 2023-2026 Priority Guidance Plan includes a project on “Guidance under section 482 regarding the transfer of intangible property,” which will likely increase scrutiny on IP royalty arrangements. The Hong Kong IRD and the IRS have exchanged information under the TIEA since 2014, and the IRS has issued summonses to Hong Kong financial institutions for account information related to US persons.

State Tax Considerations

A US person living in Hong Kong may still have state tax filing obligations if they maintain a domicile in a state with an income tax (e.g., California, New York). These states generally tax worldwide income of residents and may tax royalty income from Hong Kong IP. A US person who has moved to Hong Kong should take steps to formally change their domicile to a no-income-tax state (e.g., Texas, Florida, Nevada) before the move, including surrendering a driver’s license, changing voter registration, and establishing a new primary residence. Failure to do so can result in the state taxing the Hong Kong royalty income as if the taxpayer were still a resident.

Actionable Takeaways

1. A US person in Hong Kong receiving periodic royalty payments from a Hong Kong entity must report the income as ordinary income on their US tax return; attempting to characterize such payments as capital gain from a sale will likely fail IRS scrutiny under the Pickren factors.
2. For a US person who created the IP through personal efforts, IRC § 1221(a)(3) mandates ordinary income treatment on any sale, making a lump-sum sale to a Hong Kong entity taxable at ordinary rates up to 37%.
3. The Hong Kong profits tax paid on the gross royalty (4.95%) is creditable against US tax liability under IRC § 901, but the FTC is limited to the US tax attributable to the foreign-source income; a US person with high US tax liability may still owe residual US tax.
4. A US person considering expatriation must include IP assets in the deemed sale calculation under IRC § 877A, with the character of the gain determined by the same ordinary income vs. capital gain rules; professional valuation of the IP is essential.
5. The IRS’s 2024-2025 focus on cross-border IP transactions means that any related-party licensing arrangement between a US person in Hong Kong and a Hong Kong entity must be supported by contemporaneous transfer pricing documentation and an arm’s length royalty rate.

---

本文不構成稅務建議。涉及個人稅務情況請諮詢持牌會計師或稅務師。
This does not constitute tax advice. Consult a licensed CPA or tax advisor for your specific situation.